AU8305491A - Novel immunosuppressant peptides - Google Patents
Novel immunosuppressant peptidesInfo
- Publication number
- AU8305491A AU8305491A AU83054/91A AU8305491A AU8305491A AU 8305491 A AU8305491 A AU 8305491A AU 83054/91 A AU83054/91 A AU 83054/91A AU 8305491 A AU8305491 A AU 8305491A AU 8305491 A AU8305491 A AU 8305491A
- Authority
- AU
- Australia
- Prior art keywords
- novel immunosuppressant
- peptides
- immunosuppressant peptides
- novel
- immunosuppressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56061590A | 1990-08-01 | 1990-08-01 | |
US560615 | 1990-08-01 | ||
US65448291A | 1991-02-12 | 1991-02-12 | |
US654482 | 1991-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8305491A true AU8305491A (en) | 1992-03-02 |
Family
ID=27072401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU83054/91A Abandoned AU8305491A (en) | 1990-08-01 | 1991-07-29 | Novel immunosuppressant peptides |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU8305491A (en) |
IE (1) | IE912701A1 (en) |
IL (1) | IL99008A0 (en) |
MX (1) | MX9100454A (en) |
PT (1) | PT98501A (en) |
WO (1) | WO1992002543A1 (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993005011A1 (en) * | 1991-08-29 | 1993-03-18 | Sandoz Ltd. | Novel immunosuppressants |
US7252829B1 (en) | 1998-06-17 | 2007-08-07 | Idm Pharma, Inc. | HLA binding peptides and their uses |
US7611713B2 (en) | 1993-03-05 | 2009-11-03 | Pharmexa Inc. | Inducing cellular immune responses to hepatitis B virus using peptide compositions |
US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
US5405940A (en) | 1992-08-31 | 1995-04-11 | Ludwig Institute For Cancer Research | Isolated nonapeptides derived from MAGE genes and uses thereof |
ATE378406T1 (en) | 1992-08-31 | 2007-11-15 | Ludwig Inst Cancer Res | ISOLATED NONAPEPTIDE DERIVED FROM THE MAGE-3 GENE AND PRESENTED BY HLA-A1 AND ITS APPLICATIONS |
US6222012B1 (en) | 1992-08-31 | 2001-04-24 | Ludwig Institute For Cancer Research | Isolated nonapeptides presented by HLA molecules, and uses thereof |
US5589458A (en) * | 1992-11-13 | 1996-12-31 | Thomas Jefferson University | Compounds that inhibit T cell proliferation and methods for using the same |
US5385918A (en) * | 1993-02-09 | 1995-01-31 | Miles Inc. | Aminomethylene-peptides as immunosuppressants |
ATE415173T1 (en) | 1993-09-14 | 2008-12-15 | Pharmexa Inc | PAN DR BINDING PROTEINS TO INCREASE THE IMMUNE RESPONSE |
US6413935B1 (en) | 1993-09-14 | 2002-07-02 | Epimmune Inc. | Induction of immune response against desired determinants |
US6509165B1 (en) | 1994-07-08 | 2003-01-21 | Trustees Of Dartmouth College | Detection methods for type I diabetes |
WO1996040753A1 (en) * | 1995-06-07 | 1996-12-19 | G.D. Searle & Co. | Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis |
WO1997026538A1 (en) * | 1996-01-19 | 1997-07-24 | Virginia Mason Research Center | Allele-specific peptide epitope strategy for vaccine development |
GB9702377D0 (en) * | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
PL330348A1 (en) | 1996-06-07 | 1999-05-10 | Zeneca Ltd | Peptidic derivatives |
GB9621836D0 (en) | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
GB9624562D0 (en) | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
US6413517B1 (en) | 1997-01-23 | 2002-07-02 | Epimmune, Inc. | Identification of broadly reactive DR restricted epitopes |
FR2763071B1 (en) * | 1997-05-07 | 2003-05-16 | Centre Nat Rech Scient | PEPTIDE ANALOGS AND THEIR USES IN PARTICULAR IN PHARMACEUTICAL COMPOSITIONS AND FOR DIAGNOSIS |
IL140592A0 (en) * | 1998-07-23 | 2002-02-10 | Harvard College | Synthetic peptides and methods of use for autoimmune disease therapies |
IL141021A0 (en) | 1998-07-23 | 2002-02-10 | Yeda Res & Dev | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
ES2527760T3 (en) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Treatment of Crohn's disease with copolymer 1 and polypeptides |
US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
WO2000027417A1 (en) * | 1998-11-12 | 2000-05-18 | Yeda Research And Development Co. Ltd. | Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating gvhd and hvgd |
US7053043B1 (en) | 1999-07-23 | 2006-05-30 | Yeda Research And Development Co.Ltd. | Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD |
AU1661201A (en) | 1999-11-18 | 2001-05-30 | Epimmune, Inc. | Heteroclitic analogs and related methods |
US7026443B1 (en) | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
NZ532199A (en) | 2001-10-03 | 2008-02-29 | Harvard College | Copolymers for suppression of autoimmune diseases, and methods of use |
MXPA04005433A (en) | 2001-12-04 | 2004-10-11 | Teva Pharma | Processes for the measurement of the potency of glatiramer acetate. |
US7655221B2 (en) | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
CN111704651B (en) * | 2020-07-27 | 2021-10-08 | 南京安吉生物科技有限公司 | Polypeptide RV3 and RV4 with anti-aging effect and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3514587A1 (en) * | 1985-04-23 | 1986-10-30 | Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl | PHARMACOLOGICALLY ACTIVE PEPTIDES |
WO1990008161A1 (en) * | 1989-01-12 | 1990-07-26 | The Blood Center Of Southeastern Wisconsin | Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses |
-
1991
- 1991-07-29 WO PCT/EP1991/001420 patent/WO1992002543A1/en active Application Filing
- 1991-07-29 AU AU83054/91A patent/AU8305491A/en not_active Abandoned
- 1991-07-30 IL IL99008A patent/IL99008A0/en unknown
- 1991-07-30 PT PT98501A patent/PT98501A/en not_active Application Discontinuation
- 1991-07-31 MX MX9100454A patent/MX9100454A/en unknown
- 1991-07-31 IE IE270191A patent/IE912701A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX9100454A (en) | 1992-04-01 |
PT98501A (en) | 1992-05-29 |
IE912701A1 (en) | 1992-02-12 |
WO1992002543A1 (en) | 1992-02-20 |
IL99008A0 (en) | 1992-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8305491A (en) | Novel immunosuppressant peptides | |
AU9065891A (en) | Novel renin inhibiting peptides | |
AU639126B2 (en) | Oxorapamycin | |
AU8791591A (en) | Tnf-muteins | |
AU7846991A (en) | Aminobenzodiazepines | |
AU8676291A (en) | Cyclopeptides | |
EP0448099A3 (en) | Novel peptides | |
AU9030991A (en) | Improved capacitor-sensor | |
AU7956191A (en) | Transportsystem | |
AU7804691A (en) | N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas | |
AU3977589A (en) | Novel peptides | |
AU7726391A (en) | Slitterscorer | |
AU610900B2 (en) | Immunosuppressant peptides | |
AU7203691A (en) | An umbrella | |
AU8228591A (en) | Antimicrobial peptides | |
ZA915978B (en) | Peptides | |
AU7566691A (en) | Compostor | |
AU8740291A (en) | 3d-spectacles | |
AU9118891A (en) | Conformationally constrained peptides i | |
AU9171791A (en) | N-protected aminoalkylaldehydes | |
AU7587991A (en) | Electrodermatome | |
AU8516291A (en) | Instant photograph-postcard | |
AU8984191A (en) | Thiadiazinones | |
AU8490691A (en) | Umbrella | |
EP0517916A4 (en) | Immunosuppressant |